These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 1791079)

  • 1. Efficacy and safety of cefotaxime in the management of pediatric infections.
    Jacobs RF
    Infection; 1991; 19 Suppl 6():S330-6. PubMed ID: 1791079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical efficacy of flomoxef in neonatal bacterial infection].
    Sakata H; Hirano Y; Maruyama S
    Kansenshogaku Zasshi; 1993 Mar; 67(3):212-7. PubMed ID: 8486977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serious pediatric infections.
    Kaplan SL
    Am J Med; 1990 Apr; 88(4A):18S-24S. PubMed ID: 2183605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of ceftriaxone in treatment of serious childhood infections.
    Chadwick EG; Connor EM; Shulman ST; Yogev R
    J Pediatr; 1983 Jul; 103(1):141-5. PubMed ID: 6306193
    [No Abstract]   [Full Text] [Related]  

  • 5. Consensus report: antimicrobial therapy for bacterial meningitis in infants and children.
    McCracken GH; Nelson JD; Kaplan SL; Overturf GD; Rodriguez WJ; Steele RW
    Pediatr Infect Dis J; 1987 Jun; 6(6):501-5. PubMed ID: 3615064
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy and safety of ampicillin/sulbactam and cefuroxime in the treatment of serious skin and skin structure infections in pediatric patients. UNASYN Pediatric Study Group.
    Azimi PH; Barson WJ; Janner D; Swanson R
    Pediatr Infect Dis J; 1999 Jul; 18(7):609-13. PubMed ID: 10440436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cefotaxime use in pediatric infections.
    Dajani AS
    Diagn Microbiol Infect Dis; 1995; 22(1-2):105-10. PubMed ID: 7587022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacterial infections in infants 60 days and younger: epidemiology, resistance, and implications for treatment.
    Sadow KB; Derr R; Teach SJ
    Arch Pediatr Adolesc Med; 1999 Jun; 153(6):611-4. PubMed ID: 10357302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ceftriaxone: increasing the half-life and activity of third generation cephalosporins.
    Steele RW
    Pediatr Infect Dis; 1985; 4(2):188-91. PubMed ID: 3885182
    [No Abstract]   [Full Text] [Related]  

  • 10. Albumin: a look at the evidence.
    Basta SA; Oldfield EC
    Am J Gastroenterol; 2001 Mar; 96(3):916-7. PubMed ID: 11280580
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparison of ampicillin/sulbactam versus cefotaxime in the therapy of lower respiratory tract infections in hospitalized patients.
    Jauregui L; Minns P; Hageage G
    J Chemother; 1995 Apr; 7(2):153-6. PubMed ID: 7666123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sepsis in a newborn due to Pseudomonas aeruginosa from a contaminated tub bath.
    Wareham DW
    N Engl J Med; 2001 Nov; 345(22):1644-5. PubMed ID: 11757520
    [No Abstract]   [Full Text] [Related]  

  • 13. An open, randomized, multicentre study comparing the use of low-dose ceftazidime or cefotaxime, both in combination with netilmicin, in febrile neutropenic patients. German Multicentre Study Group.
    Höffken G; Pasold R; Pflüger KH; Finke J; Fauser AA; Szelenyi H; Wagner J
    J Antimicrob Chemother; 1999 Sep; 44(3):367-76. PubMed ID: 10511404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy of bacterial sepsis and meningitis in infants and children: 1989 poll of directors of programs in pediatric infectious diseases.
    Word BM; Klein JO
    Pediatr Infect Dis J; 1989 Sep; 8(9):635-7. PubMed ID: 2797960
    [No Abstract]   [Full Text] [Related]  

  • 15. Cefotaxime therapy in children with serious infections associated with reduced host defense mechanisms.
    López EL; Bonesana NF; Rubeglio E; Schugurensky A; Sommersguter G; Grinstein S
    J Antimicrob Chemother; 1980 Sep; 6 Suppl A():249-53. PubMed ID: 6252165
    [No Abstract]   [Full Text] [Related]  

  • 16. The evaluation of efficacy and safety of cefotaxime: a review of 2500 cases.
    Young JP; Husson JM; Bruch K; Blomer RJ; Savopoulos C
    J Antimicrob Chemother; 1980 Sep; 6 Suppl A():293-300. PubMed ID: 6252175
    [No Abstract]   [Full Text] [Related]  

  • 17. Ampicillin/sulbactam compared with cefotaxime in the treatment of lower respiratory tract infections of bacterial etiology.
    Jauregui L; Minns P; Hageage G
    Adv Ther; 1995; 12(1):62-71. PubMed ID: 10150322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapeutic failure with high-dose cefotaxime in pneumococcal meningitis].
    Michaus ML; Pérez-Díaz L; de Pablos M; Lezaun MJ; López-Bayón J
    Enferm Infecc Microbiol Clin; 1997 May; 15(5):276-7. PubMed ID: 9376392
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cefotaxime in childhood infections (author's transl)].
    Garnier JM; Giraud F
    Nouv Presse Med; 1981 Feb; 10(8):629-33. PubMed ID: 6259608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized comparative study of cefepime and cefotaxime in the treatment of acute obstetric and gynaecological infections.
    Newton ER; Yeomans ER; Pastorek JG; Soper DE; Hemsell DL
    J Antimicrob Chemother; 1993 Nov; 32 Suppl B():195-204. PubMed ID: 8150763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.